The therapeutic options are rapidly expanding. Examples include etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), secukinumab (Cosentyx) and ixekizumab (Taltz). These types of drugs are expensive and may or may not be covered by health insurance plans.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Psoriasis Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Tumor Necrosis Factor Inhibitor
Interleukin Inhibitors
Others
Market Segment by Product Application
Topicals
Systemic
Biologics
Finally, the report provides detailed profile and data information analysis of leading company.
AbbVie
Amgen
Johnson & Johnson
Novartis
Eli Lilly & Company
AstraZeneca
Celgene Corporation
UCB
Merck
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Psoriasis Drugs consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Psoriasis Drugs market by identifying its various subsegments.
3.Focuses on the key global Psoriasis Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Psoriasis Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Psoriasis Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Psoriasis Drugs Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Psoriasis Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Psoriasis Drugs Segment by Type
2.1.1 Tumor Necrosis Factor Inhibitor
2.1.2 Interleukin Inhibitors
2.1.3 Others
2.2 Market Analysis by Application
2.2.1 Topicals
2.2.2 Systemic
2.2.3 Biologics
2.3 Global Psoriasis Drugs Market Comparison by Regions (2017-2027)
2.3.1 Global Psoriasis Drugs Market Size (2017-2027)
2.3.2 North America Psoriasis Drugs Status and Prospect (2017-2027)
2.3.3 Europe Psoriasis Drugs Status and Prospect (2017-2027)
2.3.4 China Psoriasis Drugs Status and Prospect (2017-2027)
2.3.5 Japan Psoriasis Drugs Status and Prospect (2017-2027)
2.3.6 Southeast Asia Psoriasis Drugs Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Psoriasis Drugs Industry Impact
2.5.1 Psoriasis Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Psoriasis Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Psoriasis Drugs Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Psoriasis Drugs Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Psoriasis Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Psoriasis Drugs Manufacturer Market Share
3.5 Top 10 Psoriasis Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Psoriasis Drugs Market
3.7 Key Manufacturers Psoriasis Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Psoriasis Drugs Industry Key Manufacturers
4.1 AbbVie
4.1.1 Compan Detail
4.1.2 AbbVie Psoriasis Drugs Product Introduction, Application and Specification
4.1.3 AbbVie 135 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 AbbVie News
4.2 Amgen
4.2.1 Compan Detail
4.2.2 Amgen Psoriasis Drugs Product Introduction, Application and Specification
4.2.3 Amgen Psoriasis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 AbbVie News
4.3 Johnson & Johnson
4.3.1 Compan Detail
4.3.2 Johnson & Johnson Psoriasis Drugs Product Introduction, Application and Specification
4.3.3 Johnson & Johnson Psoriasis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Johnson & Johnson News
4.4 Novartis
4.4.1 Compan Detail
4.4.2 Novartis Psoriasis Drugs Product Introduction, Application and Specification
4.4.3 Novartis Psoriasis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Novartis News
4.5 Eli Lilly & Company
4.5.1 Compan Detail
4.5.2 Novartis Psoriasis Drugs Product Introduction, Application and Specification
4.5.3 Eli Lilly & Company Psoriasis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Eli Lilly & Company News
4.6 AstraZeneca
4.6.1 Compan Detail
4.6.2 AstraZeneca Psoriasis Drugs Product Introduction, Application and Specification
4.6.3 AstraZeneca Psoriasis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 AstraZeneca News
4.7 Celgene Corporation
4.7.1 Compan Detail
4.7.2 Celgene Corporation Psoriasis Drugs Product Introduction, Application and Specification
4.7.3 Celgene Corporation Psoriasis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 UCB
4.8.1 Compan Detail
4.8.2 UCB Psoriasis Drugs Product Introduction, Application and Specification
4.8.3 UCB Psoriasis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 UCB News
4.9 Merck
4.9.1 Compan Detail
4.9.2 Merck Psoriasis Drugs Product Introduction, Application and Specification
4.9.3 Merck Psoriasis Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Merck News
5 Global Psoriasis Drugs Market Segment by Big Type
5.1 Global Psoriasis Drugs Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Psoriasis Drugs Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Psoriasis Drugs Revenue and Market Share by Big Type (2017-2022)
5.2 Tumor Necrosis Factor Inhibitor Sales Growth Rate and Price
5.2.1 Global Tumor Necrosis Factor Inhibitor Sales Growth Rate (2017-2022)
5.2.2 Global Tumor Necrosis Factor Inhibitor Price (2017-2022)
5.3 Interleukin Inhibitors Sales Growth Rate and Price
5.3.1 Global Interleukin Inhibitors Sales Growth Rate (2017-2022)
5.3.2 Global Interleukin Inhibitors Price (2017-2022)
5.4 Others Sales Growth Rate and Price
5.4.1 Global Others Sales Growth Rate (2017-2022)
5.4.2 Global Others Price (2017-2022)
6 Global Psoriasis Drugs Market Segment by Big Application
6.1 Global Psoriasis Drugs Sales Market Share by Big Application (2017-2022)
6.2 Topicals Sales Growth Rate (2017-2022)
6.3 Systemic Sales Growth Rate (2017-2022)
6.4 Biologics Sales Growth Rate (2017-2022)
7 Global Psoriasis Drugs Forecast
7.1 Global Psoriasis Drugs Revenue, Sales and Growth Rate (2022-2027)
7.2 Psoriasis Drugs Market Forecast by Regions (2022-2027)
7.2.1 North America Psoriasis Drugs Market Forecast (2022-2027)
7.2.2 Europe Psoriasis Drugs Market Forecast (2022-2027)
7.2.3 China Psoriasis Drugs Market Forecast (2022-2027)
7.2.4 Japan Psoriasis Drugs Market Forecast (2022-2027)
7.2.5 Southeast Asia Psoriasis Drugs Market Forecast (2022-2027)
7.2.6 Other Regions Psoriasis Drugs Market Forecast (2022-2027)
7.3 Psoriasis Drugs Market Forecast by Type (2022-2027)
7.3.1 Global Psoriasis Drugs Sales Forecast by Type (2022-2027)
7.3.2 Global Psoriasis Drugs Market Share Forecast by Type (2022-2027)
7.4 Psoriasis Drugs Market Forecast by Application (2022-2027)
7.4.1 Global Psoriasis Drugs Sales Forecast by Application (2022-2027)
7.4.2 Global Psoriasis Drugs Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Psoriasis Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Psoriasis Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Psoriasis Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Psoriasis Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Psoriasis Drugs Market Size by Big Type
Figure Global Market Share of Psoriasis Drugs by Big Type in 2021
Figure Tumor Necrosis Factor Inhibitor Picture (2017-2022)
Figure Interleukin Inhibitors Picture (2017-2022)
Global Psoriasis Drugs Market Size by Big Application
Table Global Psoriasis Drugs Market Size by Application
Figure Global Psoriasis Drugs Market Share by Big Application in 2021
Figure Topicals Picture
Figure Systemic Picture
Figure Biologics Picture
Table Global Psoriasis Drugs Comparison by Regions (M USD) (2017-2027)
Figure Global Psoriasis Drugs Market Size (Million US$) (2017-2027)
Figure North America Psoriasis Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Psoriasis Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure China Psoriasis Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Psoriasis Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Psoriasis Drugs Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Psoriasis Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Psoriasis Drugs Sales by Manufacturer (2017-2022)
Figure Global Psoriasis Drugs Sales Market Share by Manufacturer in 2021
Table Global Psoriasis Drugs Revenue by Manufacturer (2017-2022)
Figure Global Psoriasis Drugs Revenue Market Share by Manufacturer in 2021
Table Global Psoriasis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Psoriasis Drugs Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Psoriasis Drugs Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Psoriasis Drugs Market
Table Key Manufacturers Psoriasis Drugs Product Type
Table Mergers & Acquisitions Planning
Table AbbVie Company Profile
Table Psoriasis Drugs Product Introduction, Application and Specification of AbbVie
Table Psoriasis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Amgen Company Profile
Table Psoriasis Drugs Product Introduction, Application and Specification of Amgen
Table Psoriasis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Amgen Recent Development
Table Johnson & Johnson Company Profile
Table Psoriasis Drugs Product Introduction, Application and Specification of Johnson & Johnson
Table Psoriasis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Table Novartis Company Profile
Table Psoriasis Drugs Product Introduction, Application and Specification of Novartis
Table Psoriasis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Novartis Main Business
Table Novartis Recent Development
Table Eli Lilly & Company Company Profile
Table Psoriasis Drugs Product Introduction, Application and Specification of Eli Lilly & Company
Table Psoriasis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Lilly & Company Main Business
Table Eli Lilly & Company Recent Development
Table AstraZeneca Company Profile
Table Psoriasis Drugs Product Introduction, Application and Specification of AstraZeneca
Table Psoriasis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca Main Business
Table AstraZeneca Recent Development
Table Celgene Corporation Company Profile
Table Psoriasis Drugs Product Introduction, Application and Specification of Celgene Corporation
Table Psoriasis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Celgene Corporation Main Business
Table Celgene Corporation Recent Development
Table UCB Company Profile
Table Psoriasis Drugs Product Introduction, Application and Specification of UCB
Table Psoriasis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table UCB Main Business
Table UCB Recent Development
Table Merck Company Profile
Table Psoriasis Drugs Product Introduction, Application and Specification of Merck
Table Psoriasis Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck Main Business
Table Merck Recent Development
Figure Global Psoriasis Drugs Sales and Growth Rate (2017-2022)
Figure Global Psoriasis Drugs Revenue and Growth Rate (2017-2022)
Table Global Psoriasis Drugs Sales by Regions (2017-2022)
Figure Global Psoriasis Drugs Sales Market Share by Regions in 2021
Table Global Psoriasis Drugs Revenue by Regions (2017-2022)
Figure Global Psoriasis Drugs Revenue Market Share by Regions in 2021
Figure North America Psoriasis Drugs Sales and Growth Rate (2017-2022)
Figure Europe Psoriasis Drugs Sales and Growth Rate (2017-2022)
Figure China Psoriasis Drugs Sales and Growth Rate (2017-2022)
Figure Japan Psoriasis Drugs Sales and Growth Rate (2017-2022)
Figure Southeast Asia Psoriasis Drugs Sales and Growth Rate (2017-2022)
Figure Other Regions Psoriasis Drugs Sales and Growth Rate (2017-2022)
Table Global Psoriasis Drugs Sales by Big Type (2017-2022)
Table Global Psoriasis Drugs Sales Market Share by Big Type (2017-2022)
Figure Global Psoriasis Drugs Sales Market Share by Big Type in 2019
Table Global Psoriasis Drugs Revenue by Big Type (2017-2022)
Table Global Psoriasis Drugs Revenue Market Share by Big Type (2017-2022)
Table Global Psoriasis Drugs Revenue Market Share by Big Type in 2019
Figure Global Tumor Necrosis Factor Inhibitor Sales Growth Rate (2017-2022)
Figure Global Tumor Necrosis Factor Inhibitor Price (2017-2022)
Figure Global Interleukin Inhibitors Sales Growth Rate (2017-2022)
Figure Global Interleukin Inhibitors Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Table Global Psoriasis Drugs Sales by Big Application (2017-2022)
Table Global Psoriasis Drugs Sales Market Share by Big Application (2017-2022)
Figure Global Psoriasis Drugs Sales Market Share by Big Application in 2019
Figure Global Topicals Sales Growth Rate (2017-2022)
Figure Global Systemic Sales Growth Rate (2017-2022)
Figure Global Biologics Sales Growth Rate (2017-2022)
Figure Global Psoriasis Drugs Sales and Growth Rate (2022-2027)
Figure Global Psoriasis Drugs Revenue and Growth Rate (2022-2027)
Table Global Psoriasis Drugs Sales Forecast by Regions (2022-2027)
Table Global Psoriasis Drugs Market Share Forecast by Regions (2022-2027)
Figure North America Sales Psoriasis Drugs Market Forecast (2022-2027)
Figure Europe Sales Psoriasis Drugs Market Forecast (2022-2027)
Figure China Sales Psoriasis Drugs Market Forecast (2022-2027)
Figure Japan Sales Psoriasis Drugs Market Forecast (2022-2027)
Figure Southeast Asia Sales Psoriasis Drugs Market Forecast (2022-2027)
Figure Other Regions Sales Psoriasis Drugs Market Forecast (2022-2027)
Table Global Psoriasis Drugs Sales Forecast by Type (2022-2027)
Table Global Psoriasis Drugs Market Share Forecast by Type (2022-2027)
Table Global Psoriasis Drugs Sales Forecast by Application (2022-2027)
Table Global Psoriasis Drugs Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Psoriasis Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Psoriasis Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Psoriasis Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Psoriasis Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Psoriasis Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Psoriasis Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Psoriasis Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Psoriasis Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Psoriasis Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)